Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 6 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
WED-270 Clinical Profile of Patients Considered At-Risk for MASH with Fibrosis Identified Through an Ongoing Global Screening Program with Genetics
Samuel Daniels, Karin Nelander, John Eriksson, Jelena Saillard, Lutz Jermutus,Federica Tavaglione, Joao-Filipe Raposo,Marco Arrese, Alma Laura Ladrón de Guevara,Umberto Vespasiani Gentilucci, Naim Alkhouri,Jenny Blau
Journal of Hepatology (2024)
Cited0Views0Bibtex
0
0
P23 Efficacy of Elafibranor in Primary Biliary Cholangitis: Results from the Variable Double-Blind Period of ELATIVE®, a Randomised, Placebo-Controlled Phase III Trial
Christopher L Bowlus, Kris V Kowdley, Cynthia Levy,Ulus Akarca, Mario Álvares-Da-Silva,Pietro Andreone,Marco Arrese,Christophe Corpechot,Sven Francque,Michael Heneghan,Pietro Invernizzi,David Jones, Frederik Kruger,Eric Lawitz, Marlyn J Mayo,Mitchell Shiffman, Mark G Swain, José Miguel Valera, Victor Vargas Blasco,John M Vierling,Alejandra Villamil,Julie Dietrich, Doctor Jianfen Shu, Nuno Antunes,Marwan Sleiman, Nathan Touati, Jörn M Schattenberg
P23 Efficacy of elafibranor in primary biliary cholangitis results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial (2024)
Cited0Views0Bibtex
0
0
Author Statistics

#Papers: 6

#Citation: 0

H-Index: 0

G-Index: 0

Sociability: 5

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn